Boston Scientific Corporation

BSX | NYSE

Price Alert Chart Builder DCF Calculator

$43.82

+$1.84 (+4.38%)

Nov 2, 2026, 1:42 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023	Q3 2023 Sep 30, 2023	Q2 2023 Jun 30, 2023	Q1 2023 Mar 31, 2023	Q4 2022 Dec 31, 2022	Q3 2022 Sep 30, 2022	Q2 2022 Jun 30, 2022	Q1 2022 Mar 31, 2022	Q4 2021 Dec 31, 2021	Q3 2021 Sep 30, 2021	Q2 2021 Jun 30, 2021	Q1 2021 Mar 31, 2021
Revenue	21.07B	21B	20.62B	20.08B	19.35B	18.49B	17.55B	16.75B	15.91B	15.23B	14.71B	14.24B	13.76B	13.4B	13.05B	12.68B	12.57B	12.33B	12.16B	11.89B	11.47B	11.2B	10.12B
Cost of Revenue	6.24B	6.06B	6.1B	6.22B	6.76B	6.8B	6.7B	6.46B	5.98B	5.78B	5.57B	5.41B	5.28B	5.16B	5.1B	4.97B	4.87B	4.73B	4.6B	4.51B	4.53B	4.51B	4.39B
Gross Profit	14.83B	14.94B	14.52B	13.85B	12.59B	11.69B	10.85B	10.29B	9.93B	9.45B	9.14B	8.83B	8.48B	8.24B	7.95B	7.71B	7.7B	7.6B	7.56B	7.38B	6.94B	6.68B	5.73B
Operating Income	4.44B	4.51B	4.15B	3.97B	3.35B	2.98B	2.91B	2.65B	2.62B	2.51B	2.31B	2.18B	2.07B	1.98B	1.9B	1.84B	1.85B	1.83B	1.87B	1.77B	1.49B	1.31B	735M
Interest Income	n/a	n/a	n/a	n/a	22M	22M	22M	22M	22M	22M	22M	22M	4M	5M	6M	10M	7M	7M	7M	4M	3M	3M	2M
Pretax Income	3.66B	3.86B	3.74B	3.39B	3.27B	3B	2.48B	2.28B	2.2B	2.14B	2.15B	1.99B	1.88B	1.51B	1.43B	1.14B	866M	1.1B	908M	1.08B	1.21B	495M	165M
Net Income	3.49B	3.67B	3.55B	2.89B	2.79B	2.5B	2.03B	1.85B	1.79B	1.83B	1.77B	1.59B	1.23B	912M	902M	699M	653M	884M	810M	1.04B	1.1B	524M	191M
Selling & General & Admin	7.1B	7.16B	7.07B	6.89B	6.67B	6.49B	6.22B	5.98B	5.75B	5.43B	5.34B	5.19B	4.97B	4.85B	4.66B	4.51B	4.5B	4.44B	4.4B	4.36B	4.23B	4.15B	3.83B
Research & Development	2.16B	2.15B	2.13B	2.05B	1.94B	1.84B	1.69B	1.62B	1.52B	1.47B	1.44B	1.42B	1.38B	1.37B	1.34B	1.32B	1.31B	1.28B	1.25B	1.2B	1.17B	1.18B	1.12B
Other Expenses	1.13B	1.12B	1.17B	942M	624M	392M	38M	34M	36M	42M	45M	45M	46M	46M	45M	42M	40M	43M	44M	49M	52M	50M	46M
Operating Expenses	10.39B	10.43B	10.37B	9.88B	9.23B	8.72B	7.95B	7.63B	7.31B	6.94B	6.83B	6.65B	6.4B	6.26B	6.05B	5.87B	5.85B	5.77B	5.69B	5.61B	5.46B	5.38B	4.99B
Interest Expense	376M	363M	357M	354M	403M	399M	390M	375M	303M	287M	277M	272M	269M	267M	260M	488M	512M	533M	557M	351M	359M	364M	372M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	16.63B	16.49B	16.47B	16.1B	16B	15.52B	14.65B	14.09B	13.29B	12.72B	12.4B	12.06B	11.68B	11.43B	11.14B	10.84B	10.72B	10.5B	10.3B	10.12B	9.98B	9.89B	9.39B
Income Tax Expense	163M	193M	184M	493M	485M	502M	454M	436M	414M	319M	377M	393M	648M	600M	529M	443M	213M	220M	98M	37M	107M	-29M	-25M
Shares Outstanding (Basic)	1.45B	1.48B	1.48B	1.48B	1.48B	1.48B	1.48B	1.47B	1.47B	1.47B	1.47B	1.47B	1.46B	1.45B	1.44B	1.43B	1.43B	1.43B	1.43B	1.43B	1.42B	1.42B	1.42B
Shares Outstanding (Diluted)	1.45B	1.48B	1.5B	1.5B	1.5B	1.49B	1.49B	1.49B	1.49B	1.48B	1.48B	1.48B	1.48B	1.46B	1.45B	1.44B	1.44B	1.44B	1.44B	1.44B	1.44B	1.43B	1.43B
EPS (Basic)	2.37	2.48	2.40	1.96	1.89	1.70	1.38	1.26	1.22	1.25	1.21	1.08	0.82	0.60	0.59	0.45	0.42	0.58	0.53	0.69	0.73	0.33	0.10
EPS (Diluted)	2.36	2.46	2.38	1.93	1.86	1.68	1.36	1.25	1.21	1.24	1.20	1.07	0.82	0.59	0.59	0.45	0.42	0.58	0.53	0.69	0.73	0.33	0.10
EBITDA	5.41B	5.8B	5.66B	5.27B	5.02B	4.71B	4.16B	3.92B	3.74B	3.66B	3.64B	3.45B	3.32B	2.94B	2.84B	2.77B	2.51B	2.76B	2.56B	2.52B	2.66B	1.96B	1.65B
EBIT	4.34B	4.39B	4.27B	3.91B	3.67B	3.4B	2.87B	2.66B	2.5B	2.43B	2.42B	2.26B	2.15B	1.78B	1.69B	1.63B	1.38B	1.64B	1.47B	1.43B	1.56B	859M	538M
Depreciation & Amortization	1.07B	1.41B	1.39B	1.37B	1.35B	1.32B	1.29B	1.27B	1.23B	1.23B	1.22B	1.2B	1.18B	1.16B	1.15B	1.14B	1.13B	1.12B	1.1B	1.09B	1.09B	1.1B	1.11B